Velocity’s research site in Greenville was founded in 2006 as part of VitaLink Research, and acquired by Velocity in 2021. This site’s initial focus was on clinical trials related to Respiratory and Women’s Health. Over the years, our Greenville site has also gained expertise in vaccine and infectious disease trials. All trials are performed in accordance with ICH and FDA guidelines, and in compliance with GCP.
Centrally located between major highways and interstates, the Greenville office sits on the corner of a high-traffic intersection. The Greenville site has 12,000 square foot of dedicated research space, including 8 exam rooms and dedicated bedrooms for overnight trials and ample parking for patients. The local hospital is also located a half mile away. The Greenville team is committed to being a resource for study volunteers, to providing the highest quality of patient care with compassion and kindness and to advancing medicine through research.